Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial
Cardiff University · Nottingham University Hospitals NHS Trust · +11 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
540
total citations
- FWCI
- 23.04
- Percentile
- 100%
- References
- 34
Citations per year
Authors
16Topics & keywords
Topics
Keywords
- Arsenic trioxide
- Idarubicin
- Medicine
- Acute promyelocytic leukemia
- Internal medicine
- Regimen
- Chemotherapy
- Gastroenterology
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.